Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 12 of the 17 sources its claims cite were checked for support.
Abstract
Background The proliferation of digital technology has the potential to transform diabetes management. One of the critical aspects of modern diabetes management remains the achievement of glycemic targets to avoid acute and long-term complications. Objective This study aims to describe the landscape of evidence pertaining to the relative effectiveness or efficacy and safety of various digital interventions for the self-management of type 2 diabetes mellitus (T2DM), with a primary focus on reducing glycated hemoglobin A1c (HbA1c) levels. Methods A systematic literature review (SLR) was conducted by searching Embase, MEDLINE, and CENTRAL on April 5, 2022. Study selection, data extraction, and quality assessment were performed by 2 independent reviewers. Eligibility criteria for the SLR included randomized controlled trials (RCTs) and comparative observational studies evaluating interventions containing both human (eg, coaching) and digital components (eg, glucose meter) in adult patients with T2DM. The primary meta-analysis was restricted to studies that reported laboratory-measured HbA1c. In secondary analyses, meta-regression was performed with the intensity of coaching in the digital intervention as a categorical covariate. Results In total, 28 studies were included in this analysis. Most studies (23/28, 82%) used the reduction of HbA1c levels as the primary end point, either directly or as a part of a multicomponent outcome. In total, 21 studies reported statistically significant results with this primary end point. When stratified into 3 intervention categories by the intensity of the intervention supporting the digital health technology (analyzing all 28 studies), the success rate appeared to be proportional to the coaching intensity (ie, higher-intensity studies reported higher success rates). When the analysis was restricted to RCTs using the comparative improvement of HbA1c levels, the effectiveness of the interventions was less clear. Only half (12/23, 52%) of the included RCTs reported statistically significant results. The meta-analyses were broadly aligned with the results of the SLR. The primary analysis estimated a greater reduction in HbA1c associated with digital interventions compared with usual care (–0.31%, 95% CI –0.45% to –0.16%; P<.001). Meta-regression estimated reductions of –0.45% (95% CI –0.81% to –0.09%; P=.02), –0.29% (95% CI –0.48% to –0.11%; P=.003), and –0.28% (95% CI –0.65% to 0.09%; P=.20) associated with high-, medium-, and low-intensity interventions, respectively. Conclusions These findings suggest that reducing HbA1c levels in individuals with T2DM with the help of digital interventions is feasible, effective, and acceptable. One common feature of effective digital health interventions was the availability of timely and responsive personalized coaching by a dedicated health care professional.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis of 28 studies found that digital interventions added to usual care were associated with a modest reduction in HbA1c in adults with type 2 diabetes. Coaching intensity appeared related to success, but among randomized controlled trials only about half showed a statistically significant comparative HbA1c reduction.
Key findings
- Across 28 included studies, 21 (75%) reported statistically significant results for their primary end point; among the 23 RCTs, only 12 (52%) reported a statistically significant comparative reduction in HbA1c.
- The primary random-effects meta-analysis (20 studies; n=1637 intervention vs n=1389 usual care) estimated a mean difference in HbA1c change of –0.31% (95% CI –0.45% to –0.16%; P<.001) favoring digital interventions.
- Meta-regression estimated HbA1c reductions of –0.45% (95% CI –0.81% to –0.09%; P=.02) for high-intensity interventions, –0.29% (95% CI –0.48% to –0.11%; P=.003) for medium-intensity interventions, and –0.28% (95% CI –0.65% to 0.09%; P=.20) for low-intensity interventions.
- Most studies reported ≤20% dropout, with >30% dropout in only 3 studies; 2 of 3 studies using the Diabetes Treatment Satisfaction Questionnaire reported significant improvement in the digital intervention groups.
Methods
- Systematic literature review searched Embase, MEDLINE, and CENTRAL on April 5, 2022, plus conference abstracts from 2018-2022, selected company websites, and ClinicalTrials.gov; eligibility included RCTs and comparative observational studies of interventions with both human and digital components in adults >18 years with T2DM.
- Two independent reviewers performed study selection, data extraction, and quality assessment, using the Cochrane risk of bias tool for RCTs and ROBINS-I for nonrandomized studies; 28 studies were included.
- Random-effects meta-analyses examined mean difference in HbA1c change, with the primary analysis restricted to RCTs reporting laboratory-measured HbA1c; meta-regression used coaching intensity as a categorical covariate, with subgroup and sensitivity analyses.
Limitations
- The paper states that the intensity-related conclusions require prospective testing; heterogeneity across interventions limits generalizability; boundaries between coaching categories were difficult to draw; meta-regression and subgroup analyses had low power due to few high- and low-intensity studies; follow-up time was not investigated; only RCTs were meta-analyzed, limiting real-world generalizability; all RCTs had some risk of bias; higher-intensity interventions may carry economic and logistical burdens; and behavior change was not measured appropriately.
- The paper also notes poor adverse event reporting and a lack of clear differentiation between adherence and engagement.
- The text makes evident that the sensitivity analysis excluding CGM studies was limited because only 2 CGM studies were included.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
10 Valid · 0 Not valid · 7 Not checked · 127 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Finally, the effect size observed in this meta-analysis is similar to the one reported elsewhere investigating mobile health efficacy in diabetes treatment and management across developing and developed countries [51].”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Discussion > Principal Findings
What the sources say
- Supportedcites [51] source
The Results (Primary outcome of intervention) report a pooled HbA1c effect for mHealth versus traditional treatment and separate effects in developed and developing countries. This supports the cited paper as a source of an effect size across both settings; the comparison with the citing authors’ own estimate is their assessment. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“One of the critical goals of modern diabetes management remains the achievement of acceptable levels of glycemia to avoid the acute and long-term complications associated with T2DM [9].”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Introduction
What the sources say
- Supportedcites [9] source
The GLYCEMIC GOALS section (page unavailable) says glycemic control is fundamental to diabetes management and reports that achieving A1C targets reduces long-term microvascular complications in type 2 diabetes. INTERCURRENT ILLNESS (page unavailable) says worsening glycemic control can precipitate life-threatening acute hyperglycemic crises. The paper also emphasizes individualized targets that avoid hypoglycemia. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This unmet need can be alleviated by a wider use of digital technologies designed to help patients with their lifestyle and health-related decisions by making accessible critical data and on-demand consultations [5].”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Introduction
What the sources say
- Partly supportedcites [5] sourceExperimental — accuracy not yet measured
The Results (pp. not provided) describe a digital intervention offering reliable diabetes and lifestyle information when patients need it, along with access to nurse feedback. They propose asynchronous chat for questions between visits, but nurses would respond when their schedules allow; the paper does not support on-demand consultations. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent survey showed that the standard of care in T2DM, although generally acceptable, cannot meet the variety of patients’ needs in terms of accessibility and timeliness of psychological, emotional, and behavioral support [4].”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Introduction
What the sources say
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The Abstract Results and Conclusions report that even the best services did not meet all patients’ emotional, psychological, and behavioral support needs. The Results also describe difficulties accessing care. However, the Methods describe focus groups, not a survey, and the Results say experiences varied rather than establishing that standard care was generally acceptable. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Even the presence or absence of additional devices (such as connected weight scales [46] or accelerometers [25,34]) did not appear to make a difference.”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Discussion > Principal Findings
What the sources say
- Supportedcites [46] source
The citation is attached specifically to the example of connected weight scales. The Methods (Outcome Measures and Testing Procedures; page unavailable) state that participants’ weight was measured daily on a cellular-connected scale. The sentence’s broader comparison of studies with and without additional devices is the citing authors’ assessment, not a finding attributed specifically to this paper. (LLM, conf=0.91)
- Could not verifycites [25] sourceExperimental — accuracy not yet measured
The Training section says all participants received activity monitors, so this study does not compare outcomes with and without them. It reports no test of whether accelerometers or other additional devices made a difference; the comparison between GEM subgroups concerned blood-glucose feedback instead. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [34] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
77 more claims
Create a free account to see all 144 claims and every source verdict.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 38
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This aligns with Self-Determination Theory, which emphasizes competence, autonomy, and relatedness in chronic disease management (39) (40) (41).”
From Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the ‘TreC Diabete’ platform (TELEMECHRON Study) (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher contact intensity and tailored content are associated with larger effects.”
From Effectiveness of wearable technologies in supporting physical activity and metabolic health in adults with type 2 diabetes: a systematic-narrative hybrid review (2025) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within contemporary T2D management, nursing assumes a central role when combined with Lifestyle Medicine principles and the digitalisation of care [11,39,40,41].”
From Effectiveness of wearable technologies in supporting physical activity and metabolic health in adults with type 2 diabetes: a systematic-narrative hybrid review (2025) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A previous review has suggested that low-intensity telemedicine interventions are less effective than moderate- or high-intensity ones in supporting self-management among patients with type 2 diabetes [96].”
From Clinical Improvements From Telemedicine Interventions for Managing Type 2 Diabetes Compared With Usual Care: Systematic Review, Meta-Analysis, and Meta-Regression (2026) · cites this paper as [96]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Digital interventions reduced HbA1c by 0.31% compared to usual care (95% CI -0.45% to -0.16%; p < 0.001).”
From Digital diabetes management technologies for type 2 diabetes: a systematic review of home-based care interventions (2025) · cites this paper as [10]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > Meta-Analysis
“estimated an MD of –0.46% (95% CI –0.84% to –0.07%; P<.02).”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > Meta-Analysis
“| | High-intensity interventions | High-intensity interventions | High-intensity interventions | 4 | 4 | 4 | –0.43 (–0.78 to –0.09)b |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > SLR Results
“2 (67%) out of 3 studies reported significant improvement in DTSQ scores in the digital intervention groups, compared with usual care.”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Discussion > Principal Findings
“In the 3 studies investigating patient satisfaction using DTSQ questionnaires, all reported significant improvement in DTSQ scores in the digital intervention groups”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > SLR Results
“Out of the 4 studies, 2 (50%) studies enrolled only individuals who were overweight (BMI≥25) [31] or obese (BMI≥41) [46].”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > SLR Results
“Four studies targeted populations with low income or low socioeconomic status [20,22,32,38].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > Meta-Analysis
“For the combined high- and medium-intensity interventions, the random effects meta-analysis (16 studies) [20-23,25,27,30,33,36-43,45]”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > SLR Results
“a total of 5 studies in the low-intensity category [24,28,34,36,47]”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > Meta-Analysis
“Heterogeneity was statistically significant (Q=5.35, df=3, P<.20)”
§ Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis > Results > Meta-Analysis
“| | High-intensity interventions | High-intensity interventions | High-intensity interventions | 4 | 4 | 4 | –0.43 (–0.78 to –0.09)b | –0.43 (–0.78 to –0.09)b | –0.43 (–0.78 to –0.09)b | No | No |”
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“The Risk of Bias in Nonrandomized Studies–Interventions assessment tool [49] was used to evaluate the 5 nonrandomized interventional studies (Multimedia Appendix 8).”
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684 · cited 1×
“One of the critical goals of modern diabetes management remains the achievement of acceptable levels of glycemia to avoid the acute and long-term complications associated with T2DM [9].”
Quinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L. (2011) · Diabetes Care · doi:10.2337/dc11-0366 · Cited by 650 · cited 8×
“…the following stratification: (1) a total of 7 studies in the high-intensity category [20,22,26,35,41,45,46] (out of which 5 were RCTs) [20,22,26,41,45], (2) a total of 16 studies in the medium-intensity category [21,23,25,27,29-33,37-40, Table 2 shows reported outcomes across the 3 categories as…”
InfluentialInterventions to Support Behavioral Self-Management of Chronic Diseases
Allegrante, J. P., Wells, M. T., & Peterson, J. C. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040218-044008 · Cited by 502 · cited 2×
“The concept of self-management as an important part of long-term management of chronic diseases is gaining acceptance, and it is now considered essential for achieving long-term improvement in health outcomes and quality of life [3].”
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362 · cited 1×
“They also need assistance in building insights into their daily health-related behaviors and routines [16,17].”
Athinarayanan, S. J., Adams, R. N., Hallberg, S. J., McKenzie, A. L., Bhanpuri, N. H., Campbell, W. W., Volek, J. S., Phinney, S. D., & McCarter, J. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00348 · Cited by 324 · cited 4×
“Four studies reported the occurrence of adverse events without commenting on their relationship to digital interventions [30,31,33,42].”
InfluentialGuo, C., Ashrafian, H., Ghafur, S., Fontana, G., Gardner, C., & Prime, M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00314-2 · Cited by 316
Research works printed but not linked: 1
- Das, S, 2018, Indian J Endocrinol Metab, 22
Cited by
Ji, C., Jiang, T., Liu, L., Zhang, J., & You, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1571362 · Cited by 87
Xiao, Y., Wang, Z., Zhang, L., Xie, N., Chen, F., Song, Z., & Zhao, S. (2025) · Journal of Medical Internet Research · doi:10.2196/66441 · Cited by 24
“Research indicates that it allows HCPs to assess data in real time, reducing the necessity for outpatient visits and easing the burden on both health care facilities and patients [17].”
Laffi, A., Persiani, M., Piras, A., Meoni, A., & Raffi, M. (2025) · Healthcare · doi:10.3390/healthcare13192422 · Cited by 9
“Where available, continuous glucose monitoring with time in range and home blood pressure monitoring are incorporated [11,40,41].”
InfluentialThe forgotten - overcoming challenges in diabetes care for marginalized populations
Martinez-Cruz, M., Namasingh, N., Alexopoulos, A., Batch, B. C., Crowley, M. J., & Bosworth, H. B. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2526200 · Cited by 9
“These interventions have proven to be excellent tools for psychosocial support [149], enhancing self-management practices [150], reducing HA1C levels [151,152], and ultimately decreasing overall healthcare expenses.”
Laukka, E., Jansson, M. M., Suonnansalo, P., Ojanperä, R., Härkönen, H., Lakoma, S., & Torkki, P. M. (2025) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2025.105277 · Cited by 14
Jang, M. K., Cho, Y. K., Moon, J. Y., Min, S. H., Hwang, J. H., & Jung, C. H. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.10.008 · Cited by 9
Abdul Latif el Ejel, B., Sattar, S., Fatima, S. B., Khan, H. N., Ali, H., Iftikhar, A., Sarwer, M. A., & Mushtaq, M. (2025) · Cureus · doi:10.7759/cureus.84177 · Cited by 4
“Most studies reported statistically significant improvements in glycemic outcomes compared to standard care, with HbA1c reductions ranging from 0.24% to 0.90% [10,15].”
InfluentialJiang, S., Gao, X., Diao, H., Zhang, Y., Lu, G., Liu, X., & Li, Y. (2026) · JMIR mHealth and uHealth · doi:10.2196/70429 · Cited by 6
Zhao, Y., Fu, Y., Zhang, W., Zhao, S., & Li, H. (2024) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2024.100639 · Cited by 3
Guo, W., Soh, K. G., Soh, K. G., & Saidi, H. I. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106210 · Cited by 4
amirthalingam, S. D., Ganeson, M., Thuraisingham, C., Lee, V. K. M., Chan, C. W., Sulaiman, L. H., Ramasamy, S., Bujang, M. A., & Teng, C. L. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.105138 · Cited by 4
Development of the TBQ+D: A Novel Patient-Reported Measure of The Burden of Digital Care
Zahidy, M. A., Guevara, K., Simha, S., Borras-Osorio, M., Branda, M. E., Tran, V.-T., Ridgeway, J. L., & Montori, V. M. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s540026 · Cited by 4
Giovanazzi, A., Gios, L., Gentilini, M. A., Mastellaro, M., Bartolotta, P., Nicolussi Giacomaz, L., Eccher, C., & Inchiostro, S. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1589548 · Cited by 2
Zakaria, H., Paul, G., Debs, J., Ali, J., Almarzooqi, A., HASHEMI, A., & Almarzooqi, I. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1695381 · Cited by 3
“Systematic reviews and meta-analyses of digital health interventions have consistently shown modest reductions in HbA1c, typically in the range of – 0.3% to – 0.5%, with some variability depending on intervention intensity and population (11, 12).”
InfluentialQi, Z., Wang, M., Kang, Y. M., Zhao, C.-M., Wang, Y.-H., Gao, J., & Wang, X. (2025) · BMC Family Practice · doi:10.1186/s12875-025-03111-6 · Cited by 2
“Implementation of family doctor contracts, with team-based continuous management, follow-up of irregular attendees via telephone or SMS, and mobile app–based remote monitoring may further optimize outcomes [38].”
Can Digital Technology Revolutionize Continuous Education in Diabetes Care?
Ait-Aissa, N. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241298000 · Cited by 2
Yamada, R., Kondo, S., Xu, K., & Okazaki, S. (2025) · Systematic Reviews · doi:10.1186/s13643-025-03001-z · Cited by 2
“These markers comprise biological data, such as HbA1c and self-monitored blood glucose [57], and behavioral data, including dietary habits, medication adherence, physical activity, and insulin management [58].”
Pantanetti, P., Ronconi, V., Mancin, S., Carolis, C. D., Alberti, S., Pazzi, O., Marco, S. D., Michetti, G., Coacci, S., Mignini, V. E., et al. (2025) · Diabetology · doi:10.3390/diabetology6080080 · Cited by 3
Cai, H.-J., Liang, H., Shi, L., Rong, Y.-H., Li, J., Zhang, Y., & Ma, R. (2025) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580251380071 · Cited by 2
Garcia, J., Mordin, M., Banjara, B., Saande, C., Keyloun, K. R., Abel, J. L., Gnanasakthy, A., & Byrom, B. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02512-w · Cited by 5
Saeedian, Y., Wright, C., Jansons, P., Shen, Y., Zhang, Y., & Maddison, R. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106404 · Cited by 2
Ehrmann, D., Ruch, B., Mitter, M., Kober, J., Hermanns, N., Schäfer, V., Kulzer, B., & Silbermann, S. (2025) · Journal of Medical Internet Research · doi:10.2196/68933 · Cited by 3
“Regarding glycemic control, the meta-analyses by Kerr et al [2], Romadlon et al [3], Moschonis et al [1], and Zhang et al [4] all demonstrated significant improvements in glycated hemoglobin (HbA 1c ) with digital interventions compared with control groups.”
InfluentialMehta, T., John, T., El Zein, A., Faught, V., Nawshin, T., Chilke, T. S., Cohen, C. W., Cherrington, A., & Thirumalai, M. (2025) · JMIR Research Protocols · doi:10.2196/70271 · Cited by 2
“A systematic review and meta-analysis of 28 studies, 82% of which were randomized trials, found that high-intensity digital coaching interventions are more effective in managing T2DM when compared to usual care [26].”
Fields, S. A., Arthur, K. M., Philip, S. R., Smallman, R., Kalra, V., Yehl, K., LEE, F., & Kerr, D. E. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251322189 · Cited by 2
“17”
Self-citationMa, L., Zhao, W.-S., Wang, R., Huo, S.-S., Chu, S.-Y., Shi, L.-H., Chen, Y., & Zhong, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02183-4 · Cited by 6
“%) articles [23, 26, 28, 29, 31, 32] were categorized as moderate quality (Fig.”
Grande‐Alonso, M., García, M. B., Cristóbal-Aguado, S., Aguado-Henche, S., & Moreno‐Gómez‐Toledano, R. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.100801 · Cited by 2
Glavas, C., Ma, J., Sood, S., George, E. S., Daly, R. M., Gvozdenko, E., de Courten, B. V., Scott, D. S., & Jansons, P. (2025) · Technologies · doi:10.3390/technologies13110511 · Cited by 1
“End-users found the DVA-delivered lifestyle program both feasible and realistic for older adults with obesity and T2DM, aligning with prior studies showing increased fidelity and feasibility of such interventions [36,51–53].”
Höld, E., Hemetek, U., Tremmel, K., Aubram, T., Grüblbauer, J., Wiesholzer, M., Schwanda, M., & Stieger, S. (2025) · Diabetology · doi:10.3390/diabetology6050044 · Cited by 3
“However, recent reviews and meta-analyses show that the intensity of support impacts HbA1c levels [47,48].”
Booth, G. C., Rahman, M., Rosenzweig, M. Q., Thomas, T. H., & Schenker, Y. (2025) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2025.102328 · Cited by 1
Pérez-Marqués, M., & Saldaña, M. D. M. (2025) · Health Behavior Research · doi:10.4148/2572-1836.1292
Gao, S., Yan, M., Ding, H., & Jiang, L. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02267-1 · Cited by 2
“However, most existing syntheses have treated digital interventions as a broad and homogeneous category, often combining exercise with education, self-management support, or behavioral counseling [16–18].”
Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P. D., & Moschonis, G. (2026) · International Journal of Behavioral Medicine · doi:10.1007/s12529-026-10447-5 · Cited by 1
“In recent years, digital technology and applications provide an adjunct treatment modality for use by both patients and health care professionals alike [14].”
Haeruddin, H., Amiruddin, R., Yusuf, S., Naiem, M. F., Sidin, A. I., Wahiduddin, W., Wahyu, A., Kada, M. K. R., Ma'ge, A., & Harbaeni, H. (2026) · F1000Research · doi:10.12688/f1000research.177355.2 · Cited by 1
Lansink, C., Jong, N. B.-D., Hietbrink, E. A. G., Middelweerd, A., & Laverman, G. D. (2026) · JMIR Diabetes · doi:10.2196/84894 · Cited by 2
Digital health in managing type 2 diabetes among indigenous populations: a scoping review
Samadbeik, M., Garvey, G., Engstrom, T., Langham, E., & Sullivan, C. M. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106206 · Cited by 1
Andersen, J. A., McElfish, P. A., Selig, J. P., Li, J., Rowland, B., Hudson, J. S., Kraleti, S. S., Henske, J. A., & Mayberry, L. S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113063 · Cited by 2
Ahn, J., Yang, Y., Kim, J. Y., Pahn, J., & Jang, Y. (2025) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251361360 · Cited by 5
John, T., Mohanraj, S., Nawshin, T., Mehta, T. S., & Thirumalai, M. (2026) · JMIR Diabetes · doi:10.2196/81441
Yin, Z., Errisuriz, V. L., Cuevas, H. E., et al. (2025) · doi:10.2196/preprints.79032
Self-citationNguyen, P. V. N., Thach, P. T., Tran, H., Nguyen, H. T. H., Truong, D. L., Lam, U., Tran, V. Q., To, N. T., Luong, N. T. H., Le, D. T. T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25245-4 · Cited by 5
Kumari, R., Prathiba, P. M., Meena, M., Kalyani, B., Khichi, M. S., Saini, P., Suhashini, Monteiro, R. J., & Umar, M. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20252878
Khan, A., Mistry, H., Neville, C., Martin, H., Holliday, N., Oxford, S. W., Nduka, C. C., & Szczepura, A. K. (2025) · Journal of Medical Internet Research · doi:10.2196/67851
The global economic burden of diabetes for 190 countries 2021-50: a macroeconomic modelling study
Li, J., Zhang, R., Li, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72694-0
“Such technological integration is expected to strengthen patient – provider interactions, facilitate monitoring of disease progression and support individualized interventions, thereby effectively preventing complications 29 .”
Yin, Z., Errisuriz, V. L., Cuevas, H. E., Flores, B. E., Delfausse, L. A., Galvan, C., Wang, J., Li, C., Morfin, R., Li, S., et al. (2025) · JMIR Formative Research · doi:10.2196/79032
“Additional factors include time conflicts with family responsibilities and use of digital technologies [13].”
InfluentialSelf-citationSzekely, R., Armstrong, M., Geraghty, A. W. A., Edwards, J., Hardenberg, K., Lloyd, J., Hawkes, R. E., Ocran, N., Ramasawmy, M., Poduval, S., et al. (2026) · JMIR Research Protocols · doi:10.2196/85406 · Cited by 1
Khalil, A. D., Rasool, A., & Dawood, M. (2025) · Axis Community Research Journal (ACRJ) · doi:10.67129/rb8j4j32
Remote monitoring of blood glucose self-control: Potential in the treatment of type 2 diabetes
Суплотова, Л. А., Alieva, O. O., Golubeva, A. A., & Lyapunova, A. I. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-052
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
“…23 randomized controlled trials) indicate that structured diabetes management applications, particularly those incorporating personalized feed-back, goal setting, and patient-provider communication features, can improve HbA1c, dietary behaviors, and physical activity levels in people with T2D [31].”
Influentialmoon, H., & Hwang, S.-K. (2025) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2025.0530
“Consequently, these technologies have been shown to improve glycemic control and strengthen overall self-management capabilities, yielding positive outcomes for diabetes care [10,11].”
Turner, C. D., Patel, K., Freeman, K. D., Ruff, L., Michaels, J., Bodnar, T. W., Saslow, L. R., Henderson, J., Oshman, L. D., Richardson, C. R., et al. (2025) · doi:10.2196/preprints.75672
Kowalska, A. M., Kuls, A. A., Sobol, A. Z., Pabis, B., Wiktorowicz, J. M., Kadłubańska, M., Bulińska, N., Sinczak, Z., Zembrzuska, S., & Bajerski, S. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5544
Wisana, I. D. G., Luthfiyah, S., Triwiyanto, T., & Ismath, M. (2026) · Primary Care Diabetes · doi:10.1016/j.pcd.2026.08.004
Dalvand, A., Aazami, H., Akbarniakhaky, H., Parvar, S., Habibi, R., Mohammadi, G., Faryabi, A., & Dehghanbanadaki, H. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00272-w · Cited by 4
“Simultaneously, the rapid adoption of digital health technologies, accelerated by the COVID-19 pandemic, has led to increased research on digital interventions for diabetes self-management and remote monitoring [7, 71–74].”
Uddin, J., Fariha, T., Shumi, S. S., Rahman, F., Islam, M. A., Proma, S. S., & Sarker, B. (2026) · Nursing Reports · doi:10.3390/nursrep16060191 · Cited by 1
“A growing body of literature suggests that digital interventions can improve aspects of diabetes care, including glycemic outcomes and self-management, although the size and consistency of benefit vary across intervention types and settings [8,9].”
zhao, D., Tang, P., Chen, Y., & Jingxin, Y. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-119389
“18 This characteristic is precisely what affords participants greater autonomy and connectivity in their care.”
Dong, L., Huang, Y., Wang, X., Bu, H., Yang, Y., & Su, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1707064
The role of self-management in the rehabilitation of type 2 diabetes patients
Kryukova, I. V. (2026) · Реабилитология. · doi:10.17749/2949-5873/rehabil.2025.54
MacMillan, F., Hliounakis, H., Jaye, K. M., Mitlehner, K., Pitt, C., McBride, K. A., Osuagwu, U. L., & Simmons, D. S. (2025) · Nutrients · doi:10.3390/nu17223599 · Cited by 1
“…interventions for the management of T2D reported a greater reduction in HbA1c associated with digital interventions in comparison to standard care, with these studies finding that digital interventions were effective, feasible, and acceptable to participants in relation to this outcome [19].”
A Thematic Analysis of Sleep Behavior Self-Regulation in Young Adults with Type 1 Diabetes
Long, M., Johnson, D. A., Kang, Y., & Griggs, S. A. (2026) · Diabetology · doi:10.3390/diabetology7040080
Khan, A., Mistry, H., Neville, C., et al. (2024) · doi:10.2196/preprints.67851
Wiktorzak, N., Stasiak, O., Gawior, B., Klimas, P., Laskus, J., Koźma, G., Rudnicki, L., Kochan-Olszewska, D., Prządka, J., Lipska, J., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6451
“Their greatest clinical value is observed when smartphone applications are combined with wearable devices, behavioral interventions, and regular supervision by healthcare professionals, resulting in better metabolic control and greater patient engagement [10 – 18].”
InfluentialMak, S., Patterson, E. S., Lacko, J. E., Kinney, R. L., Der‐Mcleod, E., Chuang, V. I., Fung, C. H., & Ash, G. I. (2026) · Human Factors in Healthcare · doi:10.1016/j.hfh.2026.100139
Hamadani, A., Atif, F., Altaf, S. B., Aslam, S., Idrees, M., Nasim, S., van der Veer, S. N., & Ali, S. M. (2025) · doi:10.2196/preprints.88453
A Co-design of a digital platform to support self-management of breast cancer–related lymphoedema
Naghavi, N., Bareham, M., Cook, O., Piller, N., Chan, R. J., Beatty, L., Sherman, K. A., Kemp, E., Kichenadasse, G., Reed, R. L., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-025-10300-7
Harnessing technology for diabetes care: a review of digital therapeutics
Garg, K. R., Mishra, V., & Pandey, K. K. (2026) · BMJ Innovations · doi:10.1136/bmjinnov-2024-001340
Turner, C. D., Patel, K., Freeman, K., Ruff, L., Michaels, J., Bodnar, T. W., Saslow, L. R., Henderson, J., Oshman, L. D., Richardson, C. R., et al. (2025) · JMIR Diabetes · doi:10.2196/75672
“CGM is a key component of effective digital health interventions for T2D self-management [20] and can improve glycemic control while reducing the risk of hypoglycemia [21-24].”
Mehta, T. S., John, T., Zein, A. E., et al. (2024) · doi:10.2196/preprints.70271
Fraga, L. T. S., Floriano, J. F., da Silva, M. E., Silva, S. V., de Melo, L. P., Lessa, A. T. B., Filho, L. D. L. F., Farah, S. V. R., Rodrigues, E. R. D. S., Brigoni, A. F., et al. (2025) · Cognitus Interdisciplinary Journal · doi:10.71248/40qrvn59
Takei, S., Hamada, K., Shimizu, N., Sakurai, M., Nojiri, T., & Yahagi, N. (2026) · Journal of Diabetology · doi:10.4103/jod.jod_16_26
Abdelgader, H. E. A., Hamed, S. A. H., Sidahmed, H. A. A., Gehani, A.-L., Al-Shaikhli, A., Ali, A. E. U., Hajali, H. M. A., Elsamani, E. A. E. M., & Ahmed, A. (2026) · Cureus · doi:10.7759/cureus.106693
“However, across the literature, uncertainty remains about which components of personalization are essential for durable benefit and how consistently these interventions translate into clinically meaningful improvements across settings [2].”
Chua, J., Slater, H., Rowbotham, S. J., Hansen, P., Smith, A. J., Lord, S. M., O’Sullivan, P., Tory, B., Stinson, J., & Briggs, A. M. (2026) · Journal of Pain · doi:10.1016/j.jpain.2026.106257 · Cited by 2
Saldanha, A. Z., Boggiss, A. L., & Serlachius, A. S. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109659
Zúñiga-Tapia, R., Boixadós, M., & Encuentra, E. H. (2026) · JMIR Cancer · doi:10.2196/96858 · Cited by 1
“Follow-up beyond 6 months was uncommon, although 3 studies included assessments at or around 12 months [32,33,41], a duration generally recommended as a baseline for assessing the durability of effects and avoiding the overestimation of results [50,51].”
MEHRA, C. G., Raymond, A. M., Saboo, B., Jagadeesha, A., M., K. S., Sabharwal, M., Kumar, K., Sequeira, A., Jeny Joseline, J., & KUMAR, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1920317
“Evidence from systematic reviews and meta-analyses indicates that digital interventions can improve glycemic control, engagement, and adherence in T2D, particularly when combined with personalized coaching and continuous professional support (14).”
Lee, D.-H., Matos, L. A., Cantrell, S., Crowley, M. J., & Shaw, R. J. (2026) · Telemedicine Journal and e-Health · doi:10.1177/15305627261490004
Ehrmann, D., Ruch, B., Mitter, M., et al. (2024) · doi:10.2196/preprints.68933
Dallery, J., Tulu, B., Jenkins, S., Fitzgerald, R., Aldridge, A., Duncan, I. G., & Kerr, D. E. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261484170
Self-citationYong, A. M. L., Chan, H. N., Chong, P. L., Yung, C. K., Mulok, M. A., Musa, S., Chan, S. Y., Lee, Y., Yusof, A., chen, Y., et al. (2026) · JMIR Formative Research · doi:10.2196/94551 · Cited by 1
“A reduction threshold of ≥0.6% was selected based on prior mHealth and digital intervention literature and studies reporting weighted mean HbA 1c reductions ranging from −0.4% to −0.9% [10,11,16].”
InfluentialRaghav, S., Kumar, S., Ashraf, H., Khanna, P., & Raghav, A. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1825788
Harbaeni, H., Haeruddin, H., & Botutihe, P. A. P. (2026) · JURNAL ILMIAH KESEHATAN SANDI HUSADA · doi:10.35816/jiksh.v15i2.381
“The study was conducted at Cendrawasih Health Center, Makassar, Indonesia, from June to September 2023.”
InfluentialTěšitelová, H., Blašková, V., Dubský, M., Jůzl, M., Kábelová, A., Kouřil, P., Krejčí, H., MARHEFKOVÁ, N., Mužík, J., Petr, M., et al. (2026) · Konference o jakosti potravin a potravinových surovin / Conference on Food Quality and Safety · doi:10.11118/978-80-7701-100-6-0392
Diabetes and the role of primary care: a global perspective
Kar, P. S., Sathanapally, H., Aschner, P. J., Baatiema, L., Cheng, A., Gupta, Y., Hambling, C. E., Ma, R., Seidu, S., & Khunti, K. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00214-7
Raj, A., Hasan, M., & Shahadat, S. B. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101783 · Cited by 1
Walklin, C., Mayes, J., Freeman, S., Mangahis, E., Dias, C., Bhandari, S., Bramham, K., Burton, J. O., Campbell, J. A., Kalra, P. A., et al. (2026) · JMIR Formative Research · doi:10.2196/91438 · Cited by 1
“…interventions (DHIs) have demonstrated feasibility, acceptability, clinical effectiveness, and cost-effectiveness across a wide range of long-term conditions, including type 2 diabetes [5], hypertension [6], chronic respiratory conditions [7], chronic kidney disease (CKD) [8], and cancer [9].”
Truin, L. S., Heger, I., Deckers, K., Knops, R., Palsma, T., de Heus, R. A. A., Claassen, J. A. H. R., de Vugt, M. E., & Köhler, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261440966
“21,22 Based on this, we co-developed BreinZorg (Engl., “ BrainCare ” ) together with SCD or MCI patients and memory clinic professionals.”
Ory, M. G., Esquivel, C. H., Han, G., Towne, S. D. C., Jr., Ahn, S., & Smith, M. L. (2026) · JMIR Diabetes · doi:10.2196/87364
“However, a systematic literature review and meta-analysis revealed that digital health interventions for people with T2DM were associated with significant improvements in hemoglobin A 1c levels [26].”
Wei, Q., & Jing, C. (2025) · doi:10.1145/3759972.3760170
“Self-management [2] is a central component of T2DM care, encompassing a range of daily behaviors such as blood glucose monitoring, dietary control, physical activity, and medication adherence.”
John, T., Nawshin, T., Mohanraj, S., Mehta, T. S., & Thirumalai, M. (2025) · doi:10.2196/preprints.81441
Ojo, F., & Mafo, H. N. D. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11357006
“Digital programs that leverage CGM-based time-in-range and circadian stability metrics as intermediate feedback targets demonstrate higher patient adherence and metabolic durability than clinic-lab–dependent episodic care, which cannot resolve intra-day variation [4], [10], [11].”
InfluentialWang, X., He, F., Zhang, Q., Meng, Y., Chen, T., & Zhu, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1911349
“…that, overall, middle-aged and older adults perceive positive effects of using digital health interventions on their behavior change, disease acceptance, etc., and report improvements not only in disease-related indicators but also in mental health awareness, knowledge, and skills (4, 31, 32).”
Intelligent Dietary Guidance System for Diabetes Patients: A Web-Based Solution
Uddin, M. S. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-5447-7.ch009
Binder, M. A., Temiz, S. A., Blaskowitz, P. P. V. A., Coppers, B., Ebner, I., Petit, P., Vuillerme, N., Rudolf, S., Schlaht, V., Knitza, J., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59770-7
Rungnoei, N., Kruttakart, S., Phianthanyakam, N., Klinhom, P., Nokpaet, U., Sirikunwiwat, J., & Jaitham, B. (2026) · Journal of Health Research · doi:10.56808/2586-940x.1209
Moring, C., Brock, C., Brown, K. L., & Ford-Wade, A. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23060696
“Telehealth has emerged as a promising solution to address gaps in chronic disease management [5,6].”
Cai, S., Feng, Z., Chen, M., Liu, H., Tian, Z., Fang, Y., Xie, Q., Chen, J., Jie, R., Xie, X., et al. (2026) · Digital Health · doi:10.1177/20552076261432074 · Cited by 2
“18,19 Notably, few studies have examined the cognitive mechanisms or behavioral decision-making processes underlying e-HL practices using robust theoretical frameworks.”
Bubeck, A., Hehn, C., Barroyer, M., & Naïditch, N. (2026) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2026.100306
Sciepuro, R., Cyls, D., Czarnowska, M., & Czarnowska, N. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6305
Metadata
- Authors
- Kerr, D., Ahn, D., Waki, K., Wang, J., Breznen, B., & Klonoff, D. C.
- Affiliations
- Sutter Health (US)
- The University of Tokyo (JP)
- Florida State University (US)
- BC Research (Canada) (CA)
- Corresponding author
- Kerr, David
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2024-07-22
- Volume
- 26
- Pages
- e55757
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC11301119
- OpenAlex
- W4396946832
- Cited by
- 101
- References
- 52
- Citations by year
- 2026: 55 · 2025: 42 · 2024: 4
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, digital health interventions, diabetes self-management, glycemic control, HbA1c, mobile health, blood glucose meters, intervention effectiveness, intervention safety, usual care comparison, diabetes complications prevention
- MeSH terms
- Self-Management, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Blood Glucose Self-Monitoring, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.